ResMed
415 hedge funds and large institutions have $7.57B invested in ResMed in 2017 Q4 according to their latest regulatory filings, with 78 funds opening new positions, 152 increasing their positions, 115 reducing their positions, and 25 closing their positions.
212% more first-time investments, than exits
New positions opened: 78 | Existing positions closed: 25
78% more call options, than puts
Call options by funds: $10.3M | Put options by funds: $5.8M
32% more repeat investments, than reductions
Existing positions increased: 152 | Existing positions reduced: 115
20% more funds holding in top 10
Funds holding in top 10: 5 → 6 (+1)
15% more funds holding
Funds holding: 362 → 415 (+53)
11% more capital invested
Capital invested by funds: $6.84B → $7.57B (+$724M)
0.49% more ownership
Funds ownership: 62.49% → 62.98% (+0.49%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital World Investors
Los Angeles,
California
|
+$130M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$69.2M |
| 3 |
Renaissance Technologies
New York
|
+$19.5M |
| 4 |
GC
Guggenheim Capital
Chicago,
Illinois
|
+$18.9M |
| 5 |
JP Morgan Chase
New York
|
+$14.6M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CBOA
Commonwealth Bank of Australia
Sydney, NSW,
Australia
|
-$163M |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$44.2M |
| 3 |
HSBC Holdings
London,
United Kingdom
|
-$25.2M |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$19.2M |
| 5 |
Allianz Asset Management
Munich,
Germany
|
-$15M |
RMD Hedge Fund Activity: Q4 2017 in Review
415 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in ResMed (RMD) for Q4 2017, worth a combined $7.57B — up 11% from $6.84B a quarter earlier.
Buyers outnumbered sellers: 78 funds opened new RMD positions and 25 closed out — a net gain of 53 holders — while 152 added to existing stakes and 115 trimmed.
The largest buyer was Capital World Investors, adding an estimated $130M. The largest seller was Commonwealth Bank of Australia, cutting an estimated $163M.
- 415 institutional investors held ResMed (RMD) as of Q4 2017, up from 362 in Q3 2017.
- Funds reported $7.57B of ResMed stock for Q4 2017, up 11% quarter-over-quarter.
- 78 funds opened new ResMed positions in Q4 2017 and 25 closed out, a net change of +53 holders.
- The largest ResMed buyer in Q4 2017 was Capital World Investors, an estimated $130M added.
- The largest ResMed seller in Q4 2017 was Commonwealth Bank of Australia, an estimated $163M sold.
Based on aggregated 13F filings for Q4 2017.